Global Cough Syrup Market Forecast 2023-2032

The global cough syrup market is projected to record a CAGR of 3.62% during the forecast period, 2023-2032. The market growth is attributed to innovations in cough syrups, the growing geriatric population, and the rising prevalence of respiratory ailments.

MARKET INSIGHTS

Growing awareness about the importance of respiratory health, especially in the wake of the COVID-19 pandemic, is propelling demand for cough syrups as a preventive and therapeutic measure. Accordingly, as consumers become more proactive in managing their health, the market for cough syrups is likely to remain robust.

Further, ongoing advancements in the formulation of cough syrups have brought about a significant transformation in the cough syrup industry. Manufacturers continuously investigate fresh ingredients, delivery techniques, and combinations to provide more precise and efficient relief for various types of coughs, including those triggered by respiratory conditions, allergies, and colds. Innovations like extended-release formulas provide extended relief, enabling individuals to better manage their symptoms with reduced dosing frequency.

For example, Vicks has launched a range of cough syrups that blend natural components such as honey with menthol and eucalyptus, offering comforting relief for coughs linked to colds and respiratory problems.

REGIONAL INSIGHTS

The global cough syrup market growth evaluation includes the geographical analysis of North America, Europe, Asia-Pacific, and Rest of World. Asia-Pacific is the largest revenue-generating segment in the global cough syrup market, accredited to the demand for cough syrups as a remedy to alleviate symptoms is driven by the high prevalence of respiratory ailments.

COMPETITIVE INSIGHTS

The market includes both pharmaceutical giants and medium-sized participants, leading to a varied array of products and services. Some of the leading firms in the market include Pfizer Inc, Novartis AG, Reckitt Benckiser Group PLC, etc.

Our report offerings include:

Explore key findings of the overall market
Strategic breakdown of market dynamics (Drivers, Restraints, Opportunities, Challenges)
Market forecasts for a minimum of 9 years, along with 3 years of historical data for all segments, sub-segments, and regions
Market Segmentation caters to a thorough assessment of key segments with their market estimations
Geographical Analysis: Assessments of the mentioned regions and country-level segments with their market share
Key analytics: Porter's Five Forces Analysis, Vendor Landscape, Opportunity Matrix, Key Buying Criteria, etc.
The competitive landscape is the theoretical explanation of the key companies based on factors, market share, etc.
Company profiling: A detailed company overview, product/services offered, SCOT analysis, and recent strategic developments

Product Code: 71455

1. RESEARCH SCOPE & METHODOLOGY

1.1. STUDY OBJECTIVES
1.2. METHODOLOGY
1.3. ASSUMPTIONS & LIMITATIONS

2. EXECUTIVE SUMMARY

2.1. MARKET SIZE & ESTIMATES
2.2. MARKET OVERVIEW
2.3. SCOPE OF STUDY
2.4. CRISIS SCENARIO ANALYSIS
- 2.4.1. IMPACT OF COVID-19 ON COUGH SYRUP MARKET
- 2.4.2. IMPACT OF THE RUSSIA-UKRAINE WAR ON COUGH SYRUP MARKET
2.5. MAJOR MARKET FINDINGS
- 2.5.1. PRODUCT DIVERSIFICATION IS ON THE RISE
- 2.5.2. DOMINANCE OF OTC COUGH SYRUPS HAS DRIVEN ACCESSIBILITY
- 2.5.3. HEALTHCARE INFORMATION AVAILABILITY ON DIGITAL PLATFORMS INFLUENCES CONSUMER CHOICES

3. MARKET DYNAMICS

3.1. KEY DRIVERS
- 3.1.1. PREVALENCE OF RESPIRATORY AILMENTS
- 3.1.2. RISING GERIATRIC POPULATION
- 3.1.3. INNOVATIONS IN COUGH SYRUPS
3.2. KEY RESTRAINTS
- 3.2.1. OVER-DOSAGE CONCERNS DRIVING CONSUMERS TOWARD ALTERNATIVES
- 3.2.2. STRINGENT REGULATORY PROTOCOLS
- 3.2.3. INCREASING CASES OF COUGH SYRUP DEATHS

4. KEY ANALYTICS

4.1. KEY MARKET TRENDS
- 4.1.1. INCREASING SELF-MEDICATION TRENDS
- 4.1.2. SHIFTING CONSUMER PREFERENCE TOWARD HERBAL COUGH SYRUPS
- 4.1.3. RISING POPULARITY OF E-COMMERCE CHANNELS
- 4.1.4. COMPANIES ARE OFFERING SUGAR-FREE COUGH SYRUPS
- 4.1.5. GROWING INCLINATION TOWARD HOMEOPATHIC COUGH SYRUPS
4.2. PORTER'S FIVE FORCES ANALYSIS
- 4.2.1. BUYERS POWER
- 4.2.2. SUPPLIERS POWER
- 4.2.3. SUBSTITUTION
- 4.2.4. NEW ENTRANTS
- 4.2.5. INDUSTRY RIVALRY
4.3. GROWTH PROSPECT MAPPING
- 4.3.1. GROWTH PROSPECT MAPPING FOR UNITED STATES
- 4.3.2. GROWTH PROSPECT MAPPING FOR ITALY
- 4.3.3. GROWTH PROSPECT MAPPING FOR JAPAN
- 4.3.4. GROWTH PROSPECT MAPPING FOR MIDDLE EAST & AFRICA
4.4. MARKET MATURITY ANALYSIS
4.5. MARKET CONCENTRATION ANALYSIS
4.6. VALUE CHAIN ANALYSIS

5. MARKET BY PRODUCT TYPE

5.1. COUGH SUPPRESSANTS
- 5.1.1. MARKET FORECAST FIGURE
- 5.1.2. SEGMENT ANALYSIS
5.2. COMBINATION MEDICINES
- 5.2.1. MARKET FORECAST FIGURE
- 5.2.2. SEGMENT ANALYSIS
5.3. EXPECTORANTS
- 5.3.1. MARKET FORECAST FIGURE
- 5.3.2. SEGMENT ANALYSIS

6. MARKET BY AGE GROUP

6.1. ADULTS
- 6.1.1. MARKET FORECAST FIGURE
- 6.1.2. SEGMENT ANALYSIS
6.2. ADOLESCENTS
- 6.2.1. MARKET FORECAST FIGURE
- 6.2.2. SEGMENT ANALYSIS
6.3. PEDIATRIC
- 6.3.1. MARKET FORECAST FIGURE
- 6.3.2. SEGMENT ANALYSIS

7. MARKET BY DISTRIBUTION CHANNEL

7.1. RETAIL PHARMACIES
- 7.1.1. MARKET FORECAST FIGURE
- 7.1.2. SEGMENT ANALYSIS
7.2. HOSPITAL PHARMACIES
- 7.2.1. MARKET FORECAST FIGURE
- 7.2.2. SEGMENT ANALYSIS
7.3. E-PHARMACIES
- 7.3.1. MARKET FORECAST FIGURE
- 7.3.2. SEGMENT ANALYSIS

8. GEOGRAPHICAL ANALYSIS

8.1. NORTH AMERICA
- 8.1.1. MARKET SIZE & ESTIMATES
- 8.1.2. NORTH AMERICA COUGH SYRUP MARKET DRIVERS
- 8.1.3. NORTH AMERICA COUGH SYRUP MARKET CHALLENGES
- 8.1.4. NORTH AMERICA COUGH SYRUP MARKET REGULATORY FRAMEWORK
- 8.1.5. KEY PLAYERS IN NORTH AMERICA COUGH SYRUP MARKET
- 8.1.6. COUNTRY ANALYSIS
  - 8.1.6.1. UNITED STATES
  - 8.1.6.1.1. UNITED STATES COUGH SYRUP MARKET SIZE & OPPORTUNITIES
  - 8.1.6.2. CANADA
  - 8.1.6.2.1. CANADA COUGH SYRUP MARKET SIZE & OPPORTUNITIES
8.2. EUROPE
- 8.2.1. MARKET SIZE & ESTIMATES
- 8.2.2. EUROPE COUGH SYRUP MARKET DRIVERS
- 8.2.3. EUROPE COUGH SYRUP MARKET CHALLENGES
- 8.2.4. EUROPE COUGH SYRUP MARKET REGULATORY FRAMEWORK
- 8.2.5. KEY PLAYERS IN EUROPE COUGH SYRUP MARKET
- 8.2.6. COUNTRY ANALYSIS
  - 8.2.6.1. UNITED KINGDOM
  - 8.2.6.1.1. UNITED KINGDOM COUGH SYRUP MARKET SIZE & OPPORTUNITIES
  - 8.2.6.2. GERMANY
  - 8.2.6.2.1. GERMANY COUGH SYRUP MARKET SIZE & OPPORTUNITIES
  - 8.2.6.3. FRANCE
  - 8.2.6.3.1. FRANCE COUGH SYRUP MARKET SIZE & OPPORTUNITIES
  - 8.2.6.4. ITALY
  - 8.2.6.4.1. ITALY COUGH SYRUP MARKET SIZE & OPPORTUNITIES
  - 8.2.6.5. SPAIN
  - 8.2.6.5.1. SPAIN COUGH SYRUP MARKET SIZE & OPPORTUNITIES
  - 8.2.6.6. POLAND
  - 8.2.6.6.1. POLAND COUGH SYRUP MARKET SIZE & OPPORTUNITIES
  - 8.2.6.7. BELGIUM
  - 8.2.6.7.1. BELGIUM COUGH SYRUP MARKET SIZE & OPPORTUNITIES
  - 8.2.6.8. REST OF EUROPE
  - 8.2.6.8.1. REST OF EUROPE COUGH SYRUP MARKET SIZE & OPPORTUNITIES
8.3. ASIA-PACIFIC
- 8.3.1. MARKET SIZE & ESTIMATES
- 8.3.2. ASIA-PACIFIC COUGH SYRUP MARKET DRIVERS
- 8.3.3. ASIA-PACIFIC COUGH SYRUP MARKET CHALLENGES
- 8.3.4. ASIA-PACIFIC COUGH SYRUP MARKET REGULATORY FRAMEWORK
- 8.3.5. KEY PLAYERS IN ASIA-PACIFIC COUGH SYRUP MARKET
- 8.3.6. COUNTRY ANALYSIS
  - 8.3.6.1. CHINA
  - 8.3.6.1.1. CHINA COUGH SYRUP MARKET SIZE & OPPORTUNITIES
  - 8.3.6.2. JAPAN
  - 8.3.6.2.1. JAPAN COUGH SYRUP MARKET SIZE & OPPORTUNITIES
  - 8.3.6.3. INDIA
  - 8.3.6.3.1. INDIA COUGH SYRUP MARKET SIZE & OPPORTUNITIES
  - 8.3.6.4. SOUTH KOREA
  - 8.3.6.4.1. SOUTH KOREA COUGH SYRUP MARKET SIZE & OPPORTUNITIES
  - 8.3.6.5. INDONESIA
  - 8.3.6.5.1. INDONESIA COUGH SYRUP MARKET SIZE & OPPORTUNITIES
  - 8.3.6.6. THAILAND
  - 8.3.6.6.1. THAILAND COUGH SYRUP MARKET SIZE & OPPORTUNITIES
  - 8.3.6.7. VIETNAM
  - 8.3.6.7.1. VIETNAM COUGH SYRUP MARKET SIZE & OPPORTUNITIES
  - 8.3.6.8. AUSTRALIA & NEW ZEALAND
  - 8.3.6.8.1. AUSTRALIA & NEW ZEALAND COUGH SYRUP MARKET SIZE & OPPORTUNITIES
  - 8.3.6.9. REST OF ASIA-PACIFIC
  - 8.3.6.9.1. REST OF ASIA-PACIFIC COUGH SYRUP MARKET SIZE & OPPORTUNITIES
8.4. REST OF WORLD
- 8.4.1. MARKET SIZE & ESTIMATES
- 8.4.2. REST OF WORLD COUGH SYRUP MARKET DRIVERS
- 8.4.3. REST OF WORLD COUGH SYRUP MARKET CHALLENGES
- 8.4.4. REST OF WORLD COUGH SYRUP MARKET REGULATORY FRAMEWORK
- 8.4.5. KEY PLAYERS IN REST OF WORLD COUGH SYRUP MARKET
- 8.4.6. REGIONAL ANALYSIS
  - 8.4.6.1. LATIN AMERICA
  - 8.4.6.1.1. LATIN AMERICA COUGH SYRUP MARKET SIZE & OPPORTUNITIES
  - 8.4.6.2. MIDDLE EAST & AFRICA
  - 8.4.6.2.1. MIDDLE EAST & AFRICA COUGH SYRUP MARKET SIZE & OPPORTUNITIES

9. COMPETITIVE LANDSCAPE

9.1. KEY STRATEGIC DEVELOPMENTS
- 9.1.1. MERGERS & ACQUISITIONS
- 9.1.2. PRODUCT LAUNCHES & DEVELOPMENTS
- 9.1.3. PARTNERSHIPS & AGREEMENTS
- 9.1.4. BUSINESS EXPANSIONS & DIVESTITURES
9.2. COMPANY PROFILES
- 9.2.1. ABBOTT LABORATORIES
  - 9.2.1.1. COMPANY OVERVIEW
  - 9.2.1.2. PRODUCT LIST
  - 9.2.1.3. STRENGTHS & CHALLENGES
- 9.2.2. ACELLA PHARMACEUTICALS
  - 9.2.2.1. COMPANY OVERVIEW
  - 9.2.2.2. PRODUCT LIST
  - 9.2.2.3. STRENGTHS & CHALLENGES
- 9.2.3. ASTRAZENECA PLC
  - 9.2.3.1. COMPANY OVERVIEW
  - 9.2.3.2. PRODUCT LIST
  - 9.2.3.3. STRENGTHS & CHALLENGES
- 9.2.4. CIPLA LTD
  - 9.2.4.1. COMPANY OVERVIEW
  - 9.2.4.2. PRODUCT LIST
  - 9.2.4.3. STRENGTHS & CHALLENGES
- 9.2.5. DABUR INDIA LTD
  - 9.2.5.1. COMPANY OVERVIEW
  - 9.2.5.2. PRODUCT LIST
  - 9.2.5.3. STRENGTHS & CHALLENGES
- 9.2.6. GLENMARK PHARMACEUTICALS LTD
  - 9.2.6.1. COMPANY OVERVIEW
  - 9.2.6.2. PRODUCT LIST
  - 9.2.6.3. STRENGTHS & CHALLENGES
- 9.2.7. GSK PLC
  - 9.2.7.1. COMPANY OVERVIEW
  - 9.2.7.2. PRODUCT LIST
  - 9.2.7.3. STRENGTHS & CHALLENGES
- 9.2.8. HIMALAYA WELLNESS COMPANY
  - 9.2.8.1. COMPANY OVERVIEW
  - 9.2.8.2. PRODUCT LIST
  - 9.2.8.3. STRENGTHS & CHALLENGES
- 9.2.9. KENVUE
  - 9.2.9.1. COMPANY OVERVIEW
  - 9.2.9.2. PRODUCT LIST
  - 9.2.9.3. STRENGTHS & CHALLENGES
- 9.2.10. MERCK KGAA
  - 9.2.10.1. COMPANY OVERVIEW
  - 9.2.10.2. PRODUCT LIST
  - 9.2.10.3. STRENGTHS & CHALLENGES
- 9.2.11. NOVARTIS AG
  - 9.2.11.1. COMPANY OVERVIEW
  - 9.2.11.2. PRODUCT LIST
  - 9.2.11.3. STRENGTHS & CHALLENGES
- 9.2.12. PFIZER INC
  - 9.2.12.1. COMPANY OVERVIEW
  - 9.2.12.2. PRODUCT LIST
  - 9.2.12.3. STRENGTHS & CHALLENGES
- 9.2.13. PROCTER & GAMBLE
  - 9.2.13.1. COMPANY OVERVIEW
  - 9.2.13.2. PRODUCT LIST
  - 9.2.13.3. STRENGTHS & CHALLENGES
- 9.2.14. RECKITT BENCKISER GROUP PLC
  - 9.2.14.1. COMPANY OVERVIEW
  - 9.2.14.2. PRODUCT LIST
  - 9.2.14.3. STRENGTHS & CHALLENGES
- 9.2.15. SANOFI
  - 9.2.15.1. COMPANY OVERVIEW
  - 9.2.15.2. PRODUCT LIST
  - 9.2.15.3. STRENGTHS & CHALLENGES